SETX, senataxin, 23064

N. diseases: 133; N. variants: 39
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE These diseases are due to mutations in specific genes, some of which have been identified, such as frataxin in Friedreich ataxia, alpha-tocopherol transfer protein in ataxia with vitamin E deficiency (AVED), aprataxin in ataxia with oculomotor apraxia (AOA1), and senataxin in ataxia with oculomotor apraxia (AOA2). 17112370 2006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is a rare autosomal recessive neurodegenerative disorder characterized by cerebellar atrophy, peripheral neuropathy and oculomotor apraxia. 30642639 2019
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia (AOA) type 2 (AOA2 MIM 606002) is a recessive subtype of AOA characterized by cerebellar atrophy, oculomotor apraxia, early loss of reflexes, and peripheral neuropathy. 19593598 2010
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Homozygous and compound heterozygous mutations in SETX are associated with AOA2 disease, a recessive form of ataxia with oculomotor apraxia and neuropathy with onset of ataxia between the first and second decade of life. 24183476 2014
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). 30778901 2019
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2. 19727998 2009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive form of ataxia caused by mutations in the SETX gene. 22065524 2012
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE These include ataxia with oculomotor apraxia type1 (AOA1), ataxia with oculomotor apraxia type 2 (AOA2) and ataxia-telangiectasia-like disease (ATLD). 21324166 2011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disorder associated with mutations in the Senataxin (SETX) gene. 17593543 2007
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Senataxin, mutated in the human genetic disorder ataxia with oculomotor apraxia type 2 (AOA2), plays an important role in maintaining genome integrity by coordination of transcription, DNA replication, and the DNA damage response. 23593030 2013
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE Spinocerebellar ataxia autosomal recessive 1 (SCAR1/AOA2) is clinically characterized by an early-onset progressive cerebellar ataxia with axonal neuropathy, ocular motor apraxia, and elevation of serum alpha-fetoprotein level. 23786967 2013
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disease due to mutations in the senataxin gene, causing progressive cerebellar ataxia with peripheral neuropathy, cerebellar atrophy, occasional oculomotor apraxia and elevated alpha-feto-protein (AFP) serum level. 19696032 2009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2). 19893583 2009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE We identified six families homozygous for regions containing the autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) gene, two families homozygous for the ataxia-telangiectasia gene (ATM), two families homozygous for the ataxia with oculomotor apraxia type 1 (AOA1) gene, and one family homozygous for the AOA type 2 (AOA2) gene. 20798953 2011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE Senataxin (SETX) is an RNA/DNA helicase implicated in transcription termination and the DNA damage response and is mutated in two distinct neurological disorders: AOA2 (ataxia oculomotor apraxia 2) and ALS4 (amyotrophic lateral sclerosis 4). 24105744 2013
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE The objective of this article has been to describe the presence of a sensory neuronopathy in a patient harbouring ataxia with oculomotor apraxia type 2 (AOA2). 20869730 2010
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families. 23111195 2012
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive neurodegenerative disorder characterized by cerebellar ataxia and oculomotor apraxia. 21112256 2011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE In this paper, we document two cases of a new SETX mutation (820:A>G) combined with an established recessive SETX mutation (5927:T>G) causing ataxia with oculomotor apraxia type 2 (AOA2). 23566282 2013
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Mutations in the Senataxin gene (SETX) are associated with autosomal recessive ataxia-ocular apraxia 2 (AOA2) and autosomal dominant juvenile ALS (ALS4). 16717225 2006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Senataxin recently was identified as the mutated gene in ataxia-oculomotor apraxia 2, which is characterized by ataxia, oculomotor apraxia, and increased alpha-fetoprotein levels. 15732101 2005
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disease caused by SETX mutations in 9q34 resulting in cerebellar ataxia in association with peripheral neuropathy, cerebellar atrophy on imaging, an elevated alpha-fetoprotein (AFP) serum level, and occasional oculomotor apraxia. 18625865 2008
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 Biomarker disease BEFREE It includes at least four distinct genetic entities: ataxia-telangiectasia, ataxia-telangiectasia-like disorder, and ataxia with oculomotor apraxia type 1 (AOA1) and type 2 (AOA2). 16131425 2005
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Genetic analysis of 17 presumptively diagnosed patients revealed one case of ataxia with oculomotor apraxia type 1 (AOA1); one ataxia with oculomotor apraxia type 2 (AOA2); two types of autosomal dominant spinocerebellar ataxia (SCA5, SCA29); two CACNA1A-related ataxias; one microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR); and one autosomal dominant KIF1A-related disorder with intellectual deficit, cerebellar atrophy, spastic paraparesis, and optic nerve atrophy.The diagnostic yield was 58.8%. 30301590 2019
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
0.800 GeneticVariation disease BEFREE Ataxia with oculomotor apraxia type 2 (AOA2), a neurodegenerative disorder with juvenile to adolescent onset is caused by mutations within the SENATAXIN gene ( SETX). 19569000 2008